![Itzchak Angel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Itzchak Angel
Corporate Officer/Principal chez
APOSENSE LTD
Profil
Itzchak Angel is the founder of Accellta Ltd and currently serves as External Executive Director-Business Development at Aposense Ltd. Formerly, Dr. Angel was Principal at Synthélabo SA and Vice President-Business Development at NovoTyr Therapeutics Ltd. Education includes undergraduate and graduate degrees from Tel-Aviv University and a doctorate from the University of Hamburg conferred in 1982.
Postes actifs de Itzchak Angel
| Sociétés | Poste | Début |
|---|---|---|
| APOSENSE LTD | Corporate Officer/Principal | - |
Anciens postes connus de Itzchak Angel
| Sociétés | Poste | Fin |
|---|---|---|
NovoTyr Therapeutics Ltd.
 NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops insulin-like growth factor receptor inhibiitors | Corporate Officer/Principal | - |
Accellta Ltd.
 Accellta Ltd. BiotechnologyHealth Technology Engages in research and development of stem cell culturing | Directeur Général | - |
Synthélabo SA
 Synthélabo SA Pharmaceuticals: OtherHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Formation de Itzchak Angel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Manufactures pharmaceuticals | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aposense Ltd.
 Aposense Ltd. Pharmaceuticals: MajorHealth Technology Operates as a molecular imaging and drug development company | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops insulin-like growth factor receptor inhibiitors | Health Technology |
Accellta Ltd.
Accellta Ltd. BiotechnologyHealth Technology Engages in research and development of stem cell culturing | Health Technology |
